GEODE CAPITAL MANAGEMENT, LLC
Position in SNOA — Sonoma Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in SNOA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$32,947
-$9,526 QoQ
Shares Held
26,787
+34.3% QoQ
Ownership
0.559%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 14 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $4,788,152,578 across 66 Drug Manufacturers - Specialty & Generic names. SNOA ranks #60 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
13,289,622 | $954,992,236 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
996,598 | $539,986,694 | |
| 3 | VTRS |
Viatris Inc
|
32,807,906 | $520,989,547 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,607,196 | $393,251,799 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,138,777 | $360,469,474 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
11,302,057 | $278,143,622 | |
| 7 | ALKS |
Alkermes plc.
|
4,477,876 | $234,640,702 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,841,367 | $204,281,254 |
All Filings in SNOA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,947 | 26,787 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $42,473 | 19,941 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $57,905 | 15,908 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $68,353 | 17,617 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $50,207 | 17,617 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $36,802 | 16,805 | Shares | Defined | 2025-05-13 | |
| 2024-06-30 | $18,195 | 86,644 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $6,082 | 35,780 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,440 | 35,780 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $27,550 | 35,780 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $38,748 | 36,214 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $35,489 | 36,214 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $41,165 | 36,755 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $78,550 | 36,878 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $107,683 | 36,878 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $147,880 | 36,878 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $168,163 | 36,878 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $205,779 | 36,878 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $221,528 | 30,181 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||